4.3 Article

Aminotransferase Level and the Effects of Dual Antiplatelet in Minor Stroke or Transient Ischemic Attack: A post hoc Analysis of a Randomized Control Trial

Related references

Note: Only part of the references are listed.
Review Endocrinology & Metabolism

Metabolic syndrome: an update on diagnostic criteria, pathogenesis, and genetic links

Uzma Zafar et al.

HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2018)

Article Clinical Neurology

Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: Rationale and design

S. Claiborne Johnston et al.

INTERNATIONAL JOURNAL OF STROKE (2013)

Review Pharmacology & Pharmacy

Platelet P2Y12 receptor inhibition by thienopyridines: status and future

Italo Porto et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)

Review Pharmacology & Pharmacy

Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction

Roger K. Verbeeck

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)

Article Gastroenterology & Hepatology

Aminotransferase Levels and 20-Year Risk of Metabolic Syndrome, Diabetes, and Cardiovascular Disease

Wolfram Goessling et al.

GASTROENTEROLOGY (2008)

Review Medicine, General & Internal

Primary care: Evaluation of abnormal liver-enzyme results in asymptomatic patients.

DS Pratt et al.

NEW ENGLAND JOURNAL OF MEDICINE (2000)